MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,598,000 | -9.2% | 240,000 | 0.0% | 0.05% | -2.1% |
| Q2 2022 | $17,179,000 | -48.9% | 240,000 | -29.9% | 0.05% | -38.2% |
| Q1 2022 | $33,616,000 | +12633.3% | 342,597 | +10272.3% | 0.08% | +7500.0% |
| Q3 2021 | $264,000 | -54.1% | 3,303 | -44.0% | 0.00% | 0.0% |
| Q2 2021 | $575,000 | +14275.0% | 5,902 | +32688.9% | 0.00% | – |
| Q3 2018 | $4,000 | -99.7% | 18 | -99.6% | 0.00% | -100.0% |
| Q2 2018 | $1,271,000 | +63450.0% | 4,543 | +22615.0% | 0.00% | – |
| Q1 2018 | $2,000 | -92.3% | 20 | -93.0% | 0.00% | – |
| Q4 2017 | $26,000 | +271.4% | 286 | +75.5% | 0.00% | – |
| Q3 2017 | $7,000 | – | 163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |